Gravar-mail: FACILITY-LEVEL VARIATION IN RATES OF DEFINITIVE THERAPY FOR LOW-RISK PROSTATE CANCER AMONG MEN WITH LIMITED LIFE EXPECTANCY: AN OPPORTUNITY FOR VALUE-BASED CARE REDESIGN